Home
 

2001 Press Releases in PDF Format

January 9
SANGAMO BIOSCIENCES CEO PROVIDES CORPORATE UPDATE AT JP MORGAN H&Q HEALTHCARE CONFERENCE

January 9
SANGAMO BIOSCIENCES AND RENESSEN APPLYING GENE REGULATION TECHNOLOGY TO CREATE IMPROVED CROPS


January 16
SANGAMO BIOSCIENCES REPORTS ON-LINE PUBLICATION OF GENE REGULATION DATA IN THE JOURNAL OF BIOLOGICAL CHEMISTRY


January 25
SANGAMO BIOSCIENCES TO RELEASE FOURTH-QUARTER AND YEAR-END 2000 FINANCIAL RESULTS ON FEBRUARY 1, 2001


February 1
SANGAMO BIOSCIENCES REPORTS FOURTH-QUARTER
AND YEAR-END FINANCIAL RESULTS


March 6
SANGAMO BIOSCIENCES LICENSES CELL-BASED SELECTION SYSTEM FROM MASSACHUSETTS INSTITUTE OF TECHNOLOGY AND HARVARD UNIVERSITY


March 14
SANGAMO BIOSCIENCES GRANTED U.K. PATENT COVERING REGULATION OF GENE EXPRESSION USING ENGINEERED ZINC FINGER DNA-BINDING PROTEINS


April 5
SANGAMO BIOSCIENCES AND ONYX PHARMACEUTICALS ANNOUNCE STRATEGIC ALLIANCE TO DEVELOP NOVEL CANCER THERAPEUTICS


April 18
SANGAMO BIOSCIENCES TO RELEASE FIRST-QUARTER 2001 FINANCIAL RESULTS ON APRIL 25, 2001


April 25SANGAMO BIOSCIENCES REPORTS FIRST-QUARTER FINANCIAL RESULTS

May 7
SANGAMO BIOSCIENCES ANNOUNCES REGULATION OF OVER 300 HUMAN GENES


May 29
SANGAMO BIOSCIENCES REPORTS DEATH OF ALAN P. WOLFFE, PH.D.


May 30
SANGAMO BIOSCIENCES ANNOUNCES OPTION TO ACQUIRE GENDAQ LTD
.

May 31
SANGAMO BIOSCIENCES ANNOUNCES PRESENTATION OF FIRST PRECLINICAL DATA USING ZFP TRANSCRIPTION FACTORS
First Evidence of Physiologic Response with Potential New Therapeutic Paradigm


June 6
SANGAMO BIOSCIENCES AND THE R.W. JOHNSON &JOHNSON PHARMACEUTICAL RESEARCH INSTITUTE ESTABLISH COLLABORATIVE RESEARCH PROGRAM
Partnership to Explore Application of Novel Technology to Small Molecule Screening


June 11
SANGAMO BIOSCIENCES AND MEDAREX ANNOUNCE COLLABORATION TO DISCOVER AND DEVELOP THERAPEUTIC ANTIBODIES TO G-PROTEIN COUPLED RECEPTORS


June 26
SANGAMO BIOSCIENCES AND ZYCOS ANNOUNCE COLLABORATION TO ASSESS GENE TRANSFER TECHNOLOGY


June 28
SANGAMO BIOSCIENCES SIGNS DEFINITIVE AGREEMENT TO ACQUIRE GENDAQ LTD.
Sangamo Consolidates Leadership in the Emerging Field of Gene Regulation


July 5
SANGAMO BIOSCIENCES, INC. COMPLETES GENDAQ LTD. ACQUISITION.


July 11
CHARLES RIVER AND SANGAMO BIOSCIENCES TO COLLABORATE IN THE DEVELOPMENT OF TRANSGENIC RAT MODELS


July 12
SANGAMO BIOSCIENCES ANNOUNCES SECOND-QUARTER 2001 TELECONFERENCE


July 17
SANGAMO BIOSCIENCES ANNOUNCES SMALL MOLECULE SCREENING COLLABORATION WITH PHARMACIA


July 19
SANGAMO BIOSCIENCES REPORTS SECOND-QUARTER FINANCIAL RESULTS


August 7
SANGAMO BIOSCIENCES REPORTS PUBLICATION OF DATA IN NATURE BIOTECHNOLOGY AND METHODS IN ENZYMOLOGY
Enhanced Methods Developed to Engineer DNA-binding Proteins


September 4
SANGAMO BIOSCIENCES, INC. ANNOUNCES THE APPOINTMENT OF CARL O. PABO, PH.D. AS SENIOR VICE PRESIDENT AND CHIEF SCIENTIFIC OFFICER


October 11
SANGAMO BIOSCIENCES ANNOUNCES THIRD-QUARTER 2001 TELECONFERENCE


October 18
SANGAMO BIOSCIENCES REPORTS THIRD-QUARTER FINANCIAL RESULTS


October 18
SANGAMO BIOSCIENCES ANNOUNCES FIRST MAJOR THERAPEUTICS MILESTONE. ACHIEVEMENT TRIGGERS $1.4 MILLION PAYMENT TO SANGAMO


October 29
SANGAMO BIOSCIENCES GRANTED U.K. PATENT COVERING METHODS OF ENGINEERING ZINC FINGER DNA-BINDING PROTEINS



Contact Careers Site Map Legal Glossary